Medindia

X

iGATE Completes Phase I Testing Of Meningitis Vaccine

by Medindia Content Team on  July 28, 2006 at 12:20 PM General Health News   - G J E 4
iGATE Completes Phase I Testing Of Meningitis Vaccine
Contract research firm iGATE Clinical Research International today completed the Phase I clinical trial of a new meningococcal-A conjugate vaccine.
Advertisement

The project, which is being done in partnership between the World Health Organization (WHO) and the Program for Appropriate Technology in Health (PATH), an American NGO based in Seattle aimed at eliminating epidemic meningitis in sub-Saharan Africa.

Advertisement
Vaccine development partners include the Center for Biologics Evaluation and Research (CBER - a centre of the United States Food and Drug Administration for conjugation technology, and Serum Institute of India Limited (SIIL) for vaccine manufacturing, a company release said here today.

IGATE CRI was awarded a five-year contract by Meningitis Vaccine Project (MVP) for clinical trial services spanning Phase I to Phase III testing that will include seven clinical trials.

The new meningococcal A vaccine is manufactured by Serum Institute of India Limited (SIIL).

IGATE CRI commenced monitoring Phase I trials in September 2004 in India and expects to initiate work on Phase II trials this year. The Phase I trial of the new vaccine was conducted in 72 subjects across three sites in India, the release said.

Source:PTI News
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
Way to go iGATE. This just again goes to prove the quality of clinical research that can be done out of India. With leaders like iGATE global pharma companies have a one stop shop
guest Friday, July 28, 2006

You May Also Like

Advertisement
View All